A Duckweed Cuts Down Sugar Levels in Diabetics: Harvard Study
By Huey Freeman Mankai, a small, nutrient-packed duckweed, has a significant impact on the blood sugar level of Type 2 diabetics, according to a new study. Researchers from Harvard University and Israeli universities conducted the study at two locations in Israel and observed the effects of Mankai, a type of aquatic plant that floats in large quantities in water…
More Stories
Jefferies Financial Group (NYSE:JEF) Reaches New 12-Month High – Time to Buy?
Jefferies Financial Group Inc. (NYSE:JEF – Get Free Report) hit a new 52-week high during trading on Monday . The...
iShares Core Conservative Allocation ETF (NYSEARCA:AOK) Sees Strong Trading Volume – Here’s Why
iShares Core Conservative Allocation ETF (NYSEARCA:AOK – Get Free Report) saw unusually-strong trading volume on Monday . Approximately 266,878 shares...
NYLI Hedge Multi-Strategy Tracker ETF (NYSEARCA:QAI) Sees Large Volume Increase – Here’s Why
Shares of NYLI Hedge Multi-Strategy Tracker ETF (NYSEARCA:QAI – Get Free Report) saw an uptick in trading volume on Monday...
Intelligent Bio Solutions Inc. Submits 510(k) Premarket Notification to FDA for Drug Screening Technology
Intelligent Bio Solutions Inc. recently announced a significant achievement as it submitted a 510(k) premarket notification to the US Food...
MTB Metals (CVE:MTB) Stock Price Down 33.3% – Should You Sell?
MTB Metals Corp. (CVE:MTB – Get Free Report) shares traded down 33.3% during trading on Wednesday . The stock traded...
H.B. Fuller (NYSE:FUL) Sets New 12-Month Low – Should You Sell?
H.B. Fuller (NYSE:FUL – Get Free Report) shares reached a new 52-week low during mid-day trading on Monday . The...